Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).

Zeyuan Mao, Xin Li, Pengfei Wang, Hailong Yan

Journal: Expert opinion on therapeutic patents 2022;32(9):939-952

PMID: 35929879

Abstract

INTRODUCTION

Iron oxide nanoparticles (IONPs) hold the edges of great magnetic properties and fine nanoparticle characteristics, making them an attractive therapeutic agent. In the past seven years, more in-depth investigations were devoted to the intrinsic structure, magnetic properties, and biological effects of IONPs, expanding the range of their therapeutic application scenes.

AREAS COVERED

This review focuses on the development of IONPs for biomedical applications from the angle of the patent literature reported during the period 2015-2021.

EXPERT OPINION

While the magnetic properties of IONPs have been extensively explored, the precise control of IONP behavior through external magnetic fields remains a challenge. Further digging into the biological effects of IONPs will facilitate the development of IONP-based immune therapies. Long-term reliable safety evaluations are of necessity and significance to promote the process of clinical translation.

Address: Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People's Republic of China.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.